University of California-Los Angeles · NeuroscienceThe NeuroShield Lab
Mersedeh Bahr Hosseini · Los Angeles, California
Research Focus
Dr. Mersedeh Bahr Hosseini's lab at UCLA focuses on developing innovative treatments for patients with acute ischemic stroke, particularly those who are not eligible for standard therapies. The lab is studying how a technique called cathodal transcranial direct current stimulation (C-tDCS) can help protect brain tissue and improve blood flow by using weak electrical currents applied to the scalp. Their research aims to optimize the dosage of this non-invasive therapy to enhance its safety and efficacy, potentially transforming the approach to stroke treatment in emergency settings.
acute ischemic strokecathodal transcranial direct current stimulationneuromodulationneuroprotectioncollateral blood flowimaging biomarkersclinical trialsstroke interventionbrain recovery
Research Aims
5AIM 01Develop a safe and effective protocol for HD C-tDCS in acute ischemic stroke patients.
AIM 02Identify optimal dosing regimens for neuromodulation therapy using imaging biomarkers.
AIM 03Enhance collateral blood flow to at-risk brain tissue after a stroke.
AIM 04Evaluate the clinical efficacy of HD C-tDCS therapy in improving patient outcomes.
AIM 05Investigate the potential of HD C-tDCS as both a standalone and adjunct therapy in stroke management.
Skills the Lab Values
transcranial direct current stimulation (tDCS)clinical trial designneuroimaging techniquespatient enrollment and assessmentdata collection and analysissafety and efficacy assessmentselectrode montage preparationvascular physiology studiesstatistical modeling using Bayesian methods
Output against the department
Publications75bottom 21% of dept.530th of 671
this lab
most publishedleast published
Citations618bottom 3% of dept.651st of 671
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.